إعلان
إعلان
IDYA
IDEAYA Biosciences, Inc. Common Stock
33.85
USDبرعاية
-0.72
-2.07%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
33.91
+0.06
+0.18%
تقارير أرباح IDYA
النسبة الإيجابية المفاجئة
IDYA تفوق 11 من 26 آخر التقديرات.
42%
التقرير التالي
بيانات التقرير القادم
١١ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$6.37M
/-$0.96
التغير الضمني من Q3 25 (Revenue/ EPS)
-96.94%
/-172.18%
التغير الضمني من Q4 24 (Revenue/ EPS)
-9.06%
/-35.57%
IDEAYA Biosciences, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, IDYA reported earnings of 1.33 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 339.34% surprise. Revenue reached 207.83 مليون, compared to an expected 5.12 مليون, with a 3958.80% difference. The market reacted with a -2.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 20 analysts forecast an EPS of -0.96 USD, with revenue projected to reach 6.37 مليون USD, implying an decrease of -172.18% EPS, and decrease of -96.94% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were IDEAYA Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, IDEAYA Biosciences, Inc. Common Stock reported EPS of $1.33, beating estimates by 339.34%, and revenue of $207.83M, 3958.8% above expectations.
How did the market react to IDEAYA Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.81%, changed from $31.36 before the earnings release to $30.48 the day after.
When is IDEAYA Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١١ فبراير ٢٠٢٦.
What are the forecasts for IDEAYA Biosciences, Inc. Common Stock's next earnings report?
Based on 20
analysts, IDEAYA Biosciences, Inc. Common Stock is expected to report EPS of -$0.96 and revenue of $6.37M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان